Clinical Trials on Primary Care

Total 179055 results

Universidad de Concepcion
Universidad de Valparaiso; Comisión Nacional de Investigación Científica y... and other collaborators

Recruiting

Pictograms to Facilitate Comprehension of Medical Indications (SIMAP)

Adherence, Medication | Primary Health Care | Asthma Chronic

Chile
Cliniques universitaires Saint-Luc- Université...

Completed

Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer

Prostate Cancer | Primary Disease

France, Belgium
Vastra Gotaland Region

Completed

Predictors of Increased Physical Activity in Patients Receiving Physical Activity on Prescription

Physical Activity | Health Behavior | Primary Health Care | Metabolic Syndrome X

Sweden
Bayer

Completed

Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)

Primary Hypertension

China
National Cancer Institute (NCI)

Terminated

Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery

Advanced Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
Instituto de Investigación Marqués de Valdecilla

Terminated

TO ASSESS THE EFFECTIVENESS OF THE INTERVENTION OF THE LOW-SODIUM DIET IN PATIENTS WITH HTA (IDI-HTA2020)

Arterial Hypertension | Diet Habit | Sodium Urine | Primary Care Center

Spain
Hamad Medical Corporation

Unknown

18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia (PMF/ET-FLT)

Essential Thrombocythemia | Primary Myelofibrosis, Prefibrotic Stage | Primary Myelofibrosis, Fibrotic Stage

Qatar
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Active, not recruiting

Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

Advanced Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States, Canada, Australia, Hong Kong, Korea, Republic of
Zhujiang Hospital

Recruiting

A Multicenter RCT Study of 3DV Technology in the Diagnosis and Treatment of PLC

Primary Liver Cancers

China
Grifols Therapeutics LLC

Completed

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral Immunodeficiency

Primary Immunodeficiency

United States
Mingzhi Zhang
Zhengzhou University

Completed

Treatment of Primary CNS Lymphoma ( FTD )

Primary CNS Lymphoma (PCNSL)

China
Mingzhi Zhang
Zhengzhou University

Unknown

Treatment of Primary CNS Lymphoma (FVD)

Primary CNS Lymphoma (PCNSL)

China
Northwell Health
Gilead Sciences

Completed

Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and Comorbidities (TEAMH)

HIV Infection Primary

United States
Eli Lilly and Company

Completed

A Study of LY3076226 in Participants With Advanced or Metastatic Cancer

Metastatic Cancer | Advanced Cancer

United States, Canada
Grifols Therapeutics LLC

Withdrawn

Study Evaluating IGSC 20% Flexible Dosing in Treatment-Experienced and Treatment-Naive Subjects With Primary Immunodeficiency

Primary Immunodeficiency

United States
Tel-Aviv Sourasky Medical Center

Unknown

The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer

Primary Liver Cancer

Israel
NYU Langone Health
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Health-related Quality of Life in Rare Kidney Stone

Cystinuria | Primary Hyperoxaluria | Dent Disease | Adenine Phosphoribosyl Transferase Deficiency

United States, Iceland
Galaxy Pharma (Pvt) Limited
Ova IVF & Reproductive Health Clinics, Karachi

Recruiting

Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF (MSP-INVO IVF)

Secondary Infertility | Primary Infertility | Low Responders | Mild to Moderate Male Factor Infertility

Pakistan
Chengdu Suncadia Medicine Co., Ltd.

Not yet recruiting

A Trial of HRS-5965 Tablets in Primary IgA Nephropathy

Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd

Recruiting

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Primary IgA Nephropathy

China
Shanghai Jiaolian Drug Research and Development...
Shanghai Pharmaceuticals Holding Co., Ltd

Recruiting

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

Primary Membranous Nephropathy

China
First Affiliated Hospital, Sun Yat-Sen University

Recruiting

Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy

Primary Membranous Nephropathy

China
Fondazione Policlinico Universitario Agostino Gemelli...
Merck Sharp & Dohme LLC

Recruiting

Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients (MITO 27)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

Italy
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma

United States
University of Utah
Bayer

Terminated

Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

United States
Guangdong Provincial People's Hospital

Unknown

Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma

Primary CNS Lymphoma

China
Beijing Mabworks Biotech Co., Ltd.

Recruiting

A Clinical Study of MIL62 in Primary Membranous Nephropathy

Primary Membranous Nephropathy

China
BeiGene

Recruiting

A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy

Primary Membranous Nephropathy

China, United Kingdom, United States
Martin-Luther-Universität Halle-Wittenberg

Completed

Autonomic Dysfunction and Inflammation in Chronic Hemodialysis Patients

Chronic Renal Failure | Autonomic Dysfunction

Germany
University of Pittsburgh
Genentech, Inc.; Novartis Pharmaceuticals

Completed

Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer (RADBEV)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

United States
University Hospital, Angers

Recruiting

Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms. (BioScoreSMP)

Essential Thrombocythemia | Myeloproliferative Disorder | Primary Myelofibrosis, Prefibrotic Stage | Primary Myelofibrosis, Fibrotic Stage

France
National Cancer Institute (NCI)

Completed

Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Stage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer | Stage IIIA Ovarian Epithelial Cancer | Stage IIIB Ovarian Epithelial Cancer | Stage IIIC Ovarian Epithelial Cancer | Stage IIIA Primary... and other conditions

United States
Karolinska Institutet
Karolinska University Hospital

Recruiting

Levosimendans Pharmacokinetics in Intensive Care Patients. An Observational Study. (LEFKIP)

Renal Failure | Acute Kidney Injury | Pharmacokinetics | Intensive Care | Metabolites

Sweden
RemeGen Co., Ltd.

Not yet recruiting

RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

Primary Peritoneal Cancer | Fallopian Tube | Epithelial Ovarian

China
The University of Queensland
University of Adelaide

Not yet recruiting

REmission in Membranous Nephropathy International Trial (REMIT) (REMIT)

Primary Membranous Nephropathy

Australia
Cerium Pharmaceuticals, Inc.

Recruiting

A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

Primary Membranous Nephropathy

United States, India, Canada
Beijing Mabworks Biotech Co., Ltd.

Recruiting

A Clinical Study of MIL62 in Primary Membranous Nephropathy

Primary Membranous Nephropathy

China
Novartis Pharmaceuticals

Recruiting

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Primary IgA Nephropathy

Japan, Korea, Republic of, United States, Denmark, France, Taiwan, Belgium, Israel, Thailand, Germany, India, Czechia, Malaysia, Argentina, Singapore, China, Australia, Norway, Turkey, United Kingdom, Brazil, Hong Kong, Netherlands, C... and more
Ionis Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy

Primary IgA Nephropathy

Canada, Australia, New Zealand, Singapore
Hoffmann-La Roche

Active, not recruiting

A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy (MAJESTY)

Primary Membranous Nephropathy

United States, China, Spain, Argentina, Brazil, France, Italy, Russian Federation, Israel, Poland, Turkey, Ukraine
Reistone Biopharma Company Limited

Active, not recruiting

Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy

Primary Membranous Nephropathy

China
Calliditas Therapeutics AB

Active, not recruiting

Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE) (Nefigard-OLE)

Primary IgA Nephropathy

Sweden
Abramson Cancer Center of the University of Pennsylvania

Terminated

Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer

Fallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Carcinoma

United States
Dana-Farber Cancer Institute
Celgene Corporation

Terminated

A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma

United States
Recepta Biopharma

Completed

Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

Brazil
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Canada
Assaf-Harofeh Medical Center

Unknown

Defining the Molecular Risk in Israeli Patients With Secondary Compared to Primary Myelofibrosis (MRMF01)

Myelofibrosis, Primary | Myelofibrosis, Post PV | Myelofibrosis, Post ET

Israel
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Computer Modelling of the Cervical Spine Movements in Cervical Dystonia (STICOB)

Cervical Dystonia, Primary

France
Research on Healthcare Performance Lab U1290

Completed

Primary Care in AURA for COVID-19 (SOPRAC)

Primary Health Care | COVID-19 Pandemic | Primary Care : Suspected and Confirmed Cases of COVID-19

France

Clinical Trials on Primary Care

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations